West Nile virus: Should pediatricians care?

被引:6
作者
Smith, Jennifer C. [1 ]
Mailman, Tim [2 ]
MacDonald, Noni E. [2 ]
机构
[1] Paediat Dalhousie Univ, IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada
[2] Dalhousie Univ, IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada
关键词
Arbovirus; West Nile virus; West Nile virus epidemiology; West Nile virus fever; Encephalitis; Meningitis; West Nile poliomyelitis; UNITED-STATES; FLACCID PARALYSIS; NEW-YORK; INFECTION; TRANSMISSION; OUTCOMES; DISEASE; INTERFERON-ALPHA-2B; IMMUNOGLOBULIN; EPIDEMIOLOGY;
D O I
10.1016/j.jinf.2014.07.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Given the recurrent serious outbreaks of West Nile Virus (WNV) in the United States over the past decade, the spread to Canada and South America, the recurrent outbreaks in Europe, and the potential for serious neurological disease even in children under 18 years, paediatricians in affected areas must consider WNV in the differential diagnosis of all children presenting with aseptic meningitis, encephalitis and acute flaccid paralysis. Additionally, given that WNV encephalitis can occur after WNV infection, suspicion for neurological WNV disease must remain high even after otherwise benign febrile illnesses if the child lives in or has traveled to an affected region. Under-diagnosis in the pediatric population is likely a serious problem, necessitating further educational efforts. More follow-up studies of WNV neurological disease in children and youth are needed to better understand the potential long-term sequelae during vulnerable times of neurodevelopment and neural remodeling. Similarly, more research is need on short and long-term fetal outcomes of maternal WNV infection. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S70 / S76
页数:7
相关论文
共 53 条
[1]   Human immunoglobulin as a treatment for West Nile virus infection [J].
Agrawal, AG ;
Petersen, LR .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :1-4
[2]   Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro [J].
Anderson, JF ;
Rahal, JJ .
EMERGING INFECTIOUS DISEASES, 2002, 8 (01) :107-108
[3]  
[Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P513
[4]   Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection [J].
Ben-Nathan, David ;
Gershoni-Yahalom, Orly ;
Samina, Itzchak ;
Khinich, Yevgeny ;
Nur, Israel ;
Laub, Orgad ;
Gottreich, Ahuva ;
Simanov, Michael ;
Porgador, Angel ;
Rager-Zisman, Bracha ;
Orr, Nadav .
BMC INFECTIOUS DISEASES, 2009, 9
[5]   Host Genetic Risk Factors for West Nile Virus Infection and Disease Progression [J].
Bigham, Abigail W. ;
Buckingham, Kati J. ;
Husain, Sofia ;
Emond, Mary J. ;
Bofferding, Kathryn M. ;
Gildersleeve, Heidi ;
Rutherford, Ann ;
Astakhova, NataliaM. ;
Perelygin, Andrey A. ;
Busch, Michael P. ;
Murray, Kristy O. ;
Sejvar, James J. ;
Green, Sharone ;
Kriesel, John ;
Brinton, Margo A. ;
Bamshad, Michael .
PLOS ONE, 2011, 6 (09)
[6]  
Bin H, 2001, ANN NY ACAD SCI, V951, P127
[7]   Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility [J].
Brault, Aaron C. .
VETERINARY RESEARCH, 2009, 40 (02)
[8]   ANTIGENIC RELATIONSHIPS BETWEEN FLAVIVIRUSES AS DETERMINED BY CROSS-NEUTRALIZATION TESTS WITH POLYCLONAL ANTISERA [J].
CALISHER, CH ;
KARABATSOS, N ;
DALRYMPLE, JM ;
SHOPE, RE ;
PORTERFIELD, JS ;
WESTAWAY, EG ;
BRANDT, WE .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :37-43
[9]  
Center for disease control and prevention, W NIL VIR US GUID SU, V4
[10]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135